Ameriprise Financial Inc Zai Lab LTD Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$22.97 - $30.58 $25,473 - $33,913	1,109 Added 6.54%	18,056 $493,000
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $28,513 - $39,519	-1,255 Reduced 6.89%	16,947 $411,000
Q2 2023 Aug 14, 2023	SELL	$25.3 - $39.67 $61,681 - $96,715	-2,438 Reduced 11.81%	18,202 $504,000
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $106,913 - $170,225	3,539 Added 20.69%	20,640 $686,000
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $149,253 - $259,318	-6,699 Reduced 28.15%	17,101 $525,000
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $300,310 - $453,889	-8,781 Reduced 26.95%	23,800 $814,000
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $15,341 - $32,937	-663 Reduced 1.99%	32,581 $1.13 Million
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $14.9 Million - $34.6 Million	-537,146 Reduced 94.17%	33,244 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $9.5 Million - $18.2 Million	173,023 Added 43.54%	570,390 $35.8 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $11.4 Million - $19.3 Million	108,442 Added 37.53%	397,367 $41.9 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $4.16 Million - $5.98 Million	33,215 Added 12.99%	288,925 $51.1 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $29.4 Million - $44.6 Million	232,753 Added 1013.87%	255,710 $34.1 Million
Q4 2020 Feb 12, 2021	SELL	$81.94 - $135.34 $620,695 - $1.03 Million	-7,575 Reduced 24.81%	22,957 $3.11 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $5,057 - $6,174	69 Added 0.23%	30,532 $2.54 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $30,317 - $51,251	-621 Reduced 2.0%	30,463 $2.5 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $201,482 - $324,123	-5,153 Reduced 14.22%	31,084 $1.6 Million
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $34,169 - $49,389	1,147 Added 3.27%	36,237 $1.51 Million
Q3 2019 Nov 14, 2019	SELL	$30.47 - $37.65 $222,339 - $274,732	-7,297 Reduced 17.22%	35,090 $1.14 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $1,157 - $1,610	45 Added 0.11%	42,387 $1.48 Million
Q1 2019 May 15, 2019	SELL	$21.71 - $31.54 $372,413 - $541,037	-17,154 Reduced 28.83%	42,342 $1.25 Million
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $93,512 - $154,623	-6,255 Reduced 9.51%	59,496 $1.38 Million
Q3 2018 Nov 14, 2018	SELL	$17.8 - $25.35 $624,317 - $889,125	-35,074 Reduced 34.79%	65,751 $1.28 Million
Q2 2018 Aug 14, 2018	BUY	$18.0 - $25.01 $4,860 - $6,752	270 Added 0.27%	100,825 $2.34 Million
Q1 2018 May 15, 2018	BUY	$20.05 - $26.96 $11,127 - $14,962	555 Added 0.56%	100,555 $2.15 Million
Q3 2017 Nov 07, 2017	BUY	$27.0 - $31.11 $2.7 Million - $3.11 Million	100,000	100,000 $2.7 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

Janus Henderson Group PLC London, X0

8.76M
Shares

$246 Million
0.11% of portfolio
Wellington Management Group LLP Boston, MA

8.44M
Shares

$237 Million
0.04% of portfolio
Capital World Investors Los Angeles, CA

6.44M
Shares

$181 Million
0.02% of portfolio
Viking Global Investors LP

1.95M
Shares

$54.9 Million
0.18% of portfolio
Bamco Inc New York, NY

1.91M
Shares

$53.6 Million
0.13% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.75B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account